Sept 28 (Reuters) – AFT Pharmaceuticals Ltd: * ENTERED INTO AN EXCLUSIVE DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT WITH MIKASASEIYAKU * UNDER DEAL, AFT GRANTS MIKASA EXCLUSIVE LICENSE TO SEEK
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Nov 13 (Reuters) - CMA CGM SA: * Q3 REVENUE $18.40 BILLION * Q3 EBITDA…
VIDEO SHOWS: PROFILE OF FIFA PRESIDENT, GIANNI INFANTINO SHOWS: In February 2016, Gianni…
Tennessee running back Daune Morris suffered a broken leg in a car accident on Friday…
By Eduardo Baptista BEIJING, Nov 13 (Reuters) - Nvidia has said US export controls have…
By Eduardo Baptista BEIJING, Nov 13 (Reuters) - Nvidia has said US export controls have…
(Adds background in paragraph 2, details on CEO search in paragraph 3, share movement in…